Skip to main navigation Skip to search Skip to main content

cDNA-directed expression of human cytochrome P450 CYP3A4 using baculovirus

  • J. T.M. Buters
  • , K. R. Korzekwa
  • , K. L. Kunze
  • , Y. Omata
  • , J. P. Hardwick
  • , F. J. Gonzalez
  • National Cancer Institute (NCI)

Research output: Contribution to journalArticlepeer-review

91 Scopus citations

Abstract

A recombinant baculovirus containing the human CYP3A4 cDNA was constructed and used to express CYP3A4 in SF9 insect cells (0.46 ± 0.13 nmol/mg protein, 103 ± 29 nmol/liter, N = 15). The enzyme represented ~2-3% of total cellular protein and could be purified by a two-column procedure to a specific content of 12.7 nmol/mg protein. Catalytic activity of the purified enzyme after reconstitution was optimum using molar ratios of CYP3A4 to cytochrome b5 to NADPH-P450 oxidoreductase of 1:3:20, respectively. The enzyme metabolized cortisol, erythromycin, testosterone, and (R)-warfarin. Recombinant baculovirus expresses the highest amounts of all expression systems published to date of catalytically intact CYP3A4. This system is an excellent alternative for the isolation and characterization of P450 forms from human liver.

Original languageEnglish
Pages (from-to)688-692
Number of pages5
JournalDrug Metabolism and Disposition
Volume22
Issue number5
StatePublished - 1994
Externally publishedYes

Fingerprint

Dive into the research topics of 'cDNA-directed expression of human cytochrome P450 CYP3A4 using baculovirus'. Together they form a unique fingerprint.

Cite this